Sign in
CompletedNo phase

Using Probability of Community-Acquired Pneumonia to Tailor Antimicrobials Among Inpatients

Key facts

Who runs it
Jonathan Baghdadi
Where
Baltimore, United StatesSee the 2 sites
Trial code
Status
Completed
People taking part
107 people enrolled
Started
1 Nov 2023
Ended
31 May 2025
Type of study
Interventional, 2 groupsOne group gets an existing treatment, for comparison.
Treatments tested
  • Electronic alert
  • Structured communication of test results
Record updated
14 April 2026

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Cannot take part
Show the full registry criteria (5)Hide the full registry criteria

Who can take part

  • Adult patients admitted to the University of Maryland Medical Center or University of Maryland Medical Center-Midtown Campus who are prescribed antibiotics for suspected community-acquired respiratory infection
  • Protocol-based diagnostic testing supports possible viral infection, either by positive molecular test or low procalcitonin value

Who cannot take part

  • Hospitalization for >72 hours prior to protocol-based diagnostic testing
  • Previous molecular testing for viral infection during the same hospital encounter
  • Severely immunosuppressed, defined as having hematologic malignancy, solid organ tumor on chemotherapy, or solid organ transplant on immunosuppression

Where in United States

  • University of Maryland Medical CenterBaltimore, United States
  • University of Maryland Medical Center - Midtown CampusBaltimore, United States

About the trial

What the trial wants to find out

The goal of this prospective randomized study is to improve antibiotic use among hospitalized patients with suspected pneumonia. An alert was built into the electronic health record to guide use of diagnostic testing based on probability of bacterial pneumonia. Patients with test results suggesting viral infection will be randomized to either: (1) receive a structured communication from the antimicrobial stewardship team to de-escalate antibiotics or (2) usual care.

The 2 groups in the trial

  • Electronic alert plus structured communication of test resultsTreatment being tested

    An electronic health record alert will guide diagnostic testing for pneumonia. For patients with low or moderate probability of bacterial pneumonia, test results will be communicated to the primary team with guidance to consider discontinuing or de-escalating antibiotics.

    Treatment: Electronic alert and Structured communication of test results

  • Electronic alert without structured communication of test resultsExisting treatment, for comparison

    An electronic health record alert will guide diagnostic testing for pneumonia. The primary care team will access and interpret test results and decide upon composition and duration of antimicrobial without external guidance.

    Treatment: Electronic alert

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Publications
Record updated
14 April 2026